Has Sean Frost, MD received payments from drug or device companies?

Yes. Drug and device makers reported $3,749 in general payments to Sean Frost, MD across 20 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Sean Frost, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Sean Frost, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Sean Frost, MD

Adult Reconstructive Orthopaedic Surgery · Nashua, NHNPI 1457375248

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $2,589 of the $3,749 with a category attached, or 69.1%. Smith+Nephew accounts for 88.7% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2022 at $2,938 and has fallen 97.9% since, to $62 in 2024.

$3,749in general payments, 2019–2025

Across 20 payments — averaging $187.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Smith+Nephew$3K
Linvatec Corporation$298
Davol Inc.$84
Zimmer Biomet$23
BD$19

What the payments were for

Travel & lodging$2,58969%
Food & beverage$1,16031%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Smith+Nephew	16	$3,325
Linvatec Corporation	1	$298
Davol Inc.	1	$84
Zimmer Biomet	1	$23
BD	1	$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few adult reconstructive orthopaedic surgery providers in New Hampshireto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024

$161,555

Medicare patients

273

Services billed

551

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	27	$352
Hydromorphone Hcl	13	$85
Amoxicillin	24	$32

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Nashua

Daniel WilsonNashua$10K
Kathleen HoganNashua$5K
Wayne MoschettiLebanon$476K
Maximillian LincolnExeter$36K
Stephen KantorLebanon$11K
Ivan TomekLebanon$11K
Daniel AustinLebanon$2K
Anthony PresuttiKeene$2K
Stephen FoxConcord$981
Ricardo GonzalesManchester$274

See the full list for New Hampshire →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →